Skip to content

Interscalene Block Alone Versus Interscalene Block With Erector Spinae Plane Block for Shoulder Arthroscopy Anesthesia

Interscalene Block Alone Versus Interscalene Block With Erector Spinae Plane Block for Shoulder Arthroscopy Anesthesia: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05646667
Enrollment
50
Registered
2022-12-12
Start date
2022-12-15
Completion date
2024-02-15
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erector Spinae Plane Block, Interscalene Block, Randomized Controlled Trial, Shoulder Arthroscopy Anesthesia

Brief summary

The aim of this study is to compare the effectiveness of interscalene brachial plexus block alone versus interscalene brachial plexus block +Erector spinae plane block in anesthesia for shoulder arthroscopy.

Detailed description

Regional anesthetic techniques can control pain effectively, both at rest and on movement, allowing earlier mobilization without the adverse effects of opioids . Among the various types of regional anesthetic techniques, the interscalene brachial plexus block is a gold standard used nerve block technique for postoperative analgesia in patients undergoing shoulder surgery, as it has consistently been shown to significantly control.

Interventions

OTHERinterscalene with Erector spinae plane block group

patients will receive interscalene brachial plexus block using 10 ml of bupivacaine 0.5% and US guided Erector spinae plane block at T2 using 10 ml of bupivacaine 0.5%.

OTHERInterscalene group

patients will receive interscalene brachial plexus block using 15 ml of bupivacaine 0.5%.

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged 18-65 years * Both genders, * BMI \< 40 kg/m2 * American Society of Anesthesiologists (ASA) physical status I-II * Scheduled for elective shoulder arthroscopy.

Exclusion criteria

* Known allergy to local anesthetics, * allergy to all opioid medications, diagnostic shoulder arthroscopic procedures, * patients with chronic opioids, * patients who converted to general anesthesia use and coagulopathy

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative fentanyl consumptionIntraoperative up to 4 hoursIf the patient complains of pain during surgery, fentanyl will be administered 1 µg/kg IV increments.

Secondary

MeasureTime frameDescription
Amount of 24hrs postoperative rescue analgesic consumption24 hours postoperativelyIntravenous meperidine (0.5 mg/kg) will be administered if numerical pain rating scale (NRS) score of more than 3.
Degree of pain by Numerical pain rating scale24 hours postoperativelyPostoperative pain (using NRS at admission) will be measured at PACU, 1h, 2hr. 4hr, 6hr, 8hr, 12hr, 18hr, and 24hrs postoperative. NRS (0 represents no pain while 10 represents the worst pain imaginable).
Time to first request of rescue analgesia.24 hours postoperativelyRescue analgesia in the form of IV meperidine (0.5 mg/kg) boluses if NRS \>3. Time to the 1st rescue analgesic request will be recorded.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026